000 01429 a2200421 4500
005 20250511225621.0
264 0 _c19900705
008 199007s 0 0 eng d
022 _a0300-0664
024 7 _a10.1111/j.1365-2265.1990.tb00869.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchmidli, R S
245 0 0 _aAminopropylidine diphosphonate (APD) in mild primary hyperparathyroidism: effect on clinical status.
_h[electronic resource]
260 _bClinical endocrinology
_cMar 1990
300 _a293-300 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBlood Pressure
650 0 4 _aCalcium
_xblood
650 0 4 _aDiphosphonates
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHyperparathyroidism
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMuscles
_xphysiopathology
650 0 4 _aPamidronate
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSingle-Blind Method
700 1 _aWilson, I
700 1 _aEspiner, E A
700 1 _aRichards, A M
700 1 _aDonald, R A
773 0 _tClinical endocrinology
_gvol. 32
_gno. 3
_gp. 293-300
856 4 0 _uhttps://doi.org/10.1111/j.1365-2265.1990.tb00869.x
_zAvailable from publisher's website
999 _c2194889
_d2194889